Q1 2024 Holdings
Filed 2024-05-15 | 37 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $181.1M | 5,617,599 | 13.5% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $167.8M | 61,907,605 | 12.5% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $161.5M | 8,707,165 | 12.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $138.4M | 1,069,000 | 10.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $61.6M | 7,423,574 | 4.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $53.5M | 358,000 | 4.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $53.2M | 2,084,841 | 4.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $51.6M | 1,875,000 | 3.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $47.9M | 1,116,867 | 3.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $44.9M | 650,000 | 3.3% |
| Verve Therapeutics Inc | COM | 92539P101 | $40.6M | 3,059,094 | 3.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $35.2M | 6,732,971 | 2.6% |
| Illumina Inc(ILMN) | COM | 452327109 | $34.1M | 248,000 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $31.0M | 326,378 | 2.3% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $28.6M | 3,136,411 | 2.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $26.7M | 524,616 | 2.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $26.7M | 1,300,000 | 2.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $25.5M | 800,000 | 1.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $22.3M | 675,000 | 1.7% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $19.0M | 857,904 | 1.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $14.9M | 1,000,000 | 1.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $13.4M | 3,206,380 | 1.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $10.7M | 2,000,000 | 0.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $10.7M | 2,360,129 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $9.4M | 1,188,349 | 0.7% |
| Codexis Inc(CDXS) | COM | 192005106 | $7.0M | 2,000,000 | 0.5% |
| Absci Corporation(ABSI) | COM | 00091E109 | $5.5M | 973,260 | 0.4% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $3.9M | 1,035,859 | 0.3% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $3.7M | 150,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.6M | 510,882 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.6M | 150,000 | 0.3% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $2.6M | 367,175 | 0.2% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CL A SHS | 37611X100 | $1.7M | 1,459,747 | 0.1% |
| Intellia Therapeutics Inc(NTLA)Call | COM | 45826J105 | $1.4M | 50,000 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $1.2M | 213,900 | 0.1% |
| Singular Genomics Systems in | COM | 82933R100 | $680.7K | 1,323,885 | 0.1% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $161.0K | 123,839 | 0.0% |